Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
How immuno-oncology M&A performed in the pharmaceutical industry in Q3 2024
Analysis of the key themes driving M&A activity reveals that immuno-oncology accounted for 18 pharmaceutical deals announced in Q3 2024,...
Q3 2024 update: immuno-oncology related patent activity in the pharmaceutical industry
The global pharmaceutical industry experienced a 37% decline in the number of immuno-oncology-related patent applications in Q3 2024 compared with...
Q3 2023 update: immuno-oncology related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that immuno-oncology accounted for 3 pharmaceutical deals announced in...
Innovation in oncology: Leading companies in gene therapy for cancers
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...